Skip to main content

Table 3 Scores of the 36-item Short Form health survey (SF-36), according to different definitions of the metabolic syndrome in men and women

From: Which insulin resistance-based definition of metabolic syndrome has superior diagnostic value in detection of poor health-related quality of life? Cross-sectional findings from Tehran Lipid and Glucose Study

 

WHO

EGIR

AACE

Men

   

 Physical functioning

79.4 (45.3)

79.2 (47.3)

76.5 (45.8)**

 Role physical

68.3 (83.1)

69.2 (89.2)

62.3 (87.5)

 Bodily pain

73.2 (45.9)

73.2 (49.5)

69.6 (48.7)

 General health

66.4 (49.1)

65.0 (52.2)

64.4 (51.0)

 Vitality

68.9 (47.1)

69.7 (51.4)

68.9 (50.3)

 Social functioning

77.5 (59.9)

72.7 (66.4)

75.1 (65.2)

 Role emotional

58.2 (102.4)

48.5 (107.1)

53.5 (104.9)

 Mental health

73.1 (46.7)

71.3 (52.1)

74.7 (51.1)

 PCS

71.8 (41.9)

71.6 (43.5)

68.2 (42.4)

 MCS

69.4 (50.3)

65.6 (53.7)

68.1 (52.6)

Women

   

 Physical functioning

76.7 (46.4)

76.4 (53.0)

72.9 (49.5)*

 Role physical

63.2 (75.8)

69.2 (86.8)

68.1 (81.3)

 Bodily pain

70.3 (43.2)

69.6 (48.5)

70.1 (45.2)

 General health

64.5 (39.5)

65.9 (44.5)

64.3 (41.7)

 Vitality

59.8 (43.4)

60.7 (50.3)

58.7 (46.8)

 Social functioning

74.4 (49.0)

76.2 (56.1)

72.4 (52.3)

 Role emotional

65.9 (81.2)

66.8 (93.4)

67.4 (86.8)

 Mental health

66.7 (41.0)

65.8 (47.2)

64.1 (43.6)

 PCS

68.7 (38.6)

70.3 (44.1)

68.9 (41.3)

 MCS

66.7 (42.1)

67.4 (48.3)

65.6 (45.2)

  1. Data represented as mean (SD)
  2. WHO, World Health Organization; EGIR, European Group for the study of Insulin Resistance; AACE, American Association of Clinical Endocrinology; PCS, physical component summary; MCS, mental component summary
  3. * 0.05 ≤ p ≤ 0.07 for poor health-related quality of life which is not significant in α = 0.05 but is significant in α = 0.10
  4. ** P < 0.05 for poor health-related quality of life